Last $97.84 USD
Change Today -0.29 / -0.30%
Volume 366.4K
MNK On Other Exchanges
Symbol
Exchange
New York
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

mallinckrodt plc (MNK) Snapshot

Open
$98.19
Previous Close
$98.13
Day High
$98.81
Day Low
$97.28
52 Week High
12/22/14 - $101.52
52 Week Low
01/6/14 - $50.47
Market Cap
11.4B
Average Volume 10 Days
1.2M
EPS TTM
$1.21
Shares Outstanding
116.3M
EX-Date
--
P/E TM
80.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for MALLINCKRODT PLC (MNK)

mallinckrodt plc (MNK) Related Businessweek News

View More BusinessWeek News

mallinckrodt plc (MNK) Details

Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical products and medical imaging agents worldwide. The company operates through two segments, Specialty Pharmaceuticals and Global Medical Imaging. The Specialty Pharmaceuticals segment provides Acthar, an injectable biopharmaceutical drug for use in various indications, including neurology, rheumatology, nephrology, and pulmonology; Ofirmev and Xartemis XR for pain indications; EXALGO extended-release tablets to treat chronic pain; and GABLOFEN injections for use in the management of spasticity of cerebral or spinal origin. It also offers generics and active pharmaceutical ingredients (API), such as hydrocodone and hydrocodone-containing tablets, oxycodone and oxycodone-containing tablets, and methylphenidate HCl extended-release tablets, as well as biologics, medicinal opioids, synthetic controlled substances, acetaminophen products, and other active ingredients. The Global Medical Imaging segment provides contrast media and delivery systems comprising ioversol and gadoversetamide injections for diagnostic imaging applications under the Optiray and Optimark brand names with pre-filled syringes and power injectors to the hospitals and imaging centers. It also offers nuclear imaging products consisting of technetium-99m generators under the Ultra-Technekow DTE brand; cold kits; and Octreoscan kits for localization of tumors. The company markets its products to physicians, pharmacists, pharmacy buyers, specialty pharmacies, radiologists, and radiology technicians, as well as distributes its products to drug wholesalers, retail pharmacy chains, hospital networks, ambulatory surgical centers, and governmental agencies; sells and distributes APIs directly or through distributors to other pharmaceutical companies; and markets and distributes nuclear imaging products to radiopharmacies and hospitals. Mallinckrodt public limited company is based in Dublin, Ireland.

5,500 Employees
Last Reported Date: 11/25/14

mallinckrodt plc (MNK) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $823.9K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $380.6K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $433.3K
Senior Vice President and General Counsel
Total Annual Compensation: $367.4K
Compensation as of Fiscal Year 2013.

mallinckrodt plc (MNK) Key Developments

Mallinckrodt public limited company(NYSE:MNK) added to S&P 500 Growth Index

Mallinckrodt public limited company(NYSE:MNK) added to S&P 500 Growth Index

Mallinckrodt public limited company(NYSE:MNK) dropped from S&P 500 Value Index

Mallinckrodt public limited company(NYSE:MNK) dropped from S&P 500 Value Index

Mallinckrodt public limited company Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 11:00 AM

Mallinckrodt public limited company Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 11:00 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Mark Christopher Trudeau, Chief Executive Officer, President, Director and Member of Portfolio Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNK:US $97.84 USD -0.29

MNK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cumberland Pharmaceuticals Inc $6.05 USD +0.33
Endo International PLC $72.10 USD +0.34
Guerbet €34.36 EUR -0.40
Ion Beam Applications €14.40 EUR -0.165
Lannett Co Inc $42.29 USD +1.79
View Industry Companies
 

Industry Analysis

MNK

Industry Average

Valuation MNK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MALLINCKRODT PLC, please visit www.mallinckrodt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.